中国医疗前沿
中國醫療前沿
중국의료전연
CHINA HEALTHCARE INNOVATION
2013年
22期
63-64
,共2页
疱疹性咽峡炎%喜炎平注射液%利巴韦林注射液%柯萨奇病毒%小儿
皰疹性嚥峽炎%喜炎平註射液%利巴韋林註射液%柯薩奇病毒%小兒
포진성인협염%희염평주사액%리파위림주사액%가살기병독%소인
Herpangina%Xiyanping injection%Ribavirin injection%Coxsackie virus%Children
目的:观察喜炎平注射液治疗小儿疱疹性咽峡炎的临床疗效。方法将2011年1月-2012年12月我院246例疱疹性咽峡炎患儿随机分为两组各123例,观察组给予喜炎平注射液治疗,对照组给予利巴韦林注射液静脉滴注。观察两组患儿体温、哭闹、拒食、流涎、疱疹或溃疡改善情况。结果观察组总有效率高于对照组(P <0.05);观察组平均退热时间、开始进食时间、哭闹不安时间、疱疹及溃疡消失时间短于对照组(P <0.05);全部病例均未见发生毒副反应。结论在常规抗菌、退热、输液治疗基础上,喜炎平注射液比利巴韦林注射液疗效显著,无毒副反应,值得临床推广。
目的:觀察喜炎平註射液治療小兒皰疹性嚥峽炎的臨床療效。方法將2011年1月-2012年12月我院246例皰疹性嚥峽炎患兒隨機分為兩組各123例,觀察組給予喜炎平註射液治療,對照組給予利巴韋林註射液靜脈滴註。觀察兩組患兒體溫、哭鬧、拒食、流涎、皰疹或潰瘍改善情況。結果觀察組總有效率高于對照組(P <0.05);觀察組平均退熱時間、開始進食時間、哭鬧不安時間、皰疹及潰瘍消失時間短于對照組(P <0.05);全部病例均未見髮生毒副反應。結論在常規抗菌、退熱、輸液治療基礎上,喜炎平註射液比利巴韋林註射液療效顯著,無毒副反應,值得臨床推廣。
목적:관찰희염평주사액치료소인포진성인협염적림상료효。방법장2011년1월-2012년12월아원246례포진성인협염환인수궤분위량조각123례,관찰조급여희염평주사액치료,대조조급여리파위림주사액정맥적주。관찰량조환인체온、곡료、거식、류연、포진혹궤양개선정황。결과관찰조총유효솔고우대조조(P <0.05);관찰조평균퇴열시간、개시진식시간、곡료불안시간、포진급궤양소실시간단우대조조(P <0.05);전부병례균미견발생독부반응。결론재상규항균、퇴열、수액치료기출상,희염평주사액비리파위림주사액료효현저,무독부반응,치득림상추엄。
Objective To observe the clinical effect of Xiyanping injection in the treatment of children with herpangina. Methods 246 cases of herpetic angina were selected from January 2011 to December 2012 in our hospital, they were randomly divided into observation group and control group, 123 cases in each group, the observation group was given Xiyanping injection treatments, while the control group was given ribavirin injection intravenous drip. Observed the improvement of temperature, crying, antifeedant, salivation, bleb or ulcer of children in the two groups. Results The total effective rate in the observation group was higher than 87.8% in the control group(P <0.05); average the defervescence time, feeding time, crying uneasy time, herpes and ulcer disappeared time in observation group shorter than the control group(P <0.05); all cases had no toxic and side reaction. Conclusion In the conventional antibacterial, antipyretic, infusion therapy, has significant effects of Xiyanping injection than ribavirin injection, and has no toxic side effect, so it is worthy of the clinical promotion.